Inhibition of Epstein-Barr virus-associated nuclear antigen (EBNA) induction by (2′,5′)oligoadenylate and the cordycepin analog: Mechanism of action for inhibition of EBV-induced transformation

This publication has 18 references indexed in Scilit:

• Interferon Enhances the Expression of Epstein--Barr Virus Early Antigen in Daudi Cells
  Journal of General Virology, 1982
• Characteristics of Epstein-Barr virus activation of human B lymphocytes.
  The Journal of Experimental Medicine, 1981
• Reversibility of the transformed and neoplastic phenotype. I. Progressive reversion of the phenotype of X-ray-transformed C3H/10T1/2 cells under prolonged treatment with interferon
  International Journal of Cancer, 1981
• Synthesis and characterization of (2′-5′)ppp3′dA(p3′dA)n, an analogue of (2′-5′)pppA(pA)n
  Nature, 1981
• Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate.
  The Journal of Experimental Medicine, 1980
• Activation of Suppressor T Cells during Epstein-Barr-Virus-Induced Infectious Mononucleosis
  New England Journal of Medicine, 1979
• Inhibition of nucleoside and sugar transport into cells by an oncostatic methylase inhibitor, 5′-deoxy-5′-S -isobutyl-thioadenosine (SIBA)
  FEBS Letters, 1979
• Surface markers on human B‐ and T‐lymphocytes. IX. Two‐color immunofluorescence studies on the association between EBV receptors and complement receptors on the surface of lymphoid cell lines
  International Journal of Cancer, 1976
• Effect of interferon on lymphocyte transformation and nuclear antigen production by Epstein–Barr virus
  Nature, 1976
• Inhibition of virus-induced cell transformation by synthetic analogues of S-adenosyl homocysteine
  Biochemical and Biophysical Research Communications, 1975